Logo image of WRD

WERIDE INC-ADR (WRD) Stock Fundamental Analysis

NASDAQ:WRD - Nasdaq - US9509151083 - ADR - Currency: USD

24.42  -3.17 (-11.49%)

After market: 24.46 +0.04 (+0.16%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WRD. WRD was compared to 83 industry peers in the Automobile Components industry. The financial health of WRD is average, but there are quite some concerns on its profitability. WRD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WRD had negative earnings in the past year.
In the past year WRD has reported a negative cash flow from operations.
WRD Yearly Net Income VS EBIT VS OCF VS FCFWRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -500M -1B -1.5B

1.2 Ratios

With a Return On Assets value of -37.77%, WRD is not doing good in the industry: 93.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -37.77%
ROE N/A
ROIC N/A
ROA(3y)-29.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WRD Yearly ROA, ROE, ROICWRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 20 -20 40 60 80 100

1.3 Margins

WRD has a better Gross Margin (45.66%) than 98.80% of its industry peers.
WRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WRD Yearly Profit, Operating, Gross MarginsWRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

WRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
WRD has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, WRD has an improved debt to assets ratio.
WRD Yearly Shares OutstandingWRD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 50M 100M 150M 200M 250M
WRD Yearly Total Debt VS Total AssetsWRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

WRD has an Altman-Z score of 2.62. This is not the best score and indicates that WRD is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.62, WRD is in the better half of the industry, outperforming 60.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 2.62
ROIC/WACCN/A
WACC7.85%
WRD Yearly LT Debt VS Equity VS FCFWRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -1B -2B -3B

2.3 Liquidity

A Current Ratio of 13.64 indicates that WRD has no problem at all paying its short term obligations.
WRD has a Current ratio of 13.64. This is amongst the best in the industry. WRD outperforms 98.80% of its industry peers.
A Quick Ratio of 12.89 indicates that WRD has no problem at all paying its short term obligations.
WRD has a Quick ratio of 12.89. This is amongst the best in the industry. WRD outperforms 98.80% of its industry peers.
Industry RankSector Rank
Current Ratio 13.64
Quick Ratio 12.89
WRD Yearly Current Assets VS Current LiabilitesWRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

0

3. Growth

3.1 Past

The earnings per share for WRD have decreased strongly by -54.38% in the last year.
The Revenue for WRD has decreased by -23.83% in the past year. This is quite bad
EPS 1Y (TTM)-54.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-23.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WRD Yearly Revenue VS EstimatesWRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 100M 200M 300M 400M 500M
WRD Yearly EPS VS EstimatesWRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WRD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WRD Price Earnings VS Forward Price EarningsWRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WRD Per share dataWRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WERIDE INC-ADR

NASDAQ:WRD (2/21/2025, 8:00:02 PM)

After market: 24.46 +0.04 (+0.16%)

24.42

-3.17 (-11.49%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap6.70B
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 121.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.2
BVpS-1.84
TBVpS-1.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.66%
FCFM N/A
ROA(3y)-29.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 101.48%
Cap/Sales 13.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.64
Quick Ratio 12.89
Altman-Z 2.62
F-ScoreN/A
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)93.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.48%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.16%
OCF growth 3YN/A
OCF growth 5YN/A